![]() |
市場調査レポート
商品コード
1593457
ヘルスケア分析試験サービス市場規模、シェア、成長分析、タイプ別、エンドユーザー別、地域別 - 産業予測、2024年~2031年Healthcare Analytical Testing Services Market Size, Share, Growth Analysis, By Type, By End User, By Region - Industry Forecast 2024-2031 |
||||||
|
ヘルスケア分析試験サービス市場規模、シェア、成長分析、タイプ別、エンドユーザー別、地域別 - 産業予測、2024年~2031年 |
出版日: 2024年11月09日
発行: SkyQuest
ページ情報: 英文 168 Pages
納期: 3~5営業日
|
世界のヘルスケア分析試験サービス市場規模は、2022年に約66億5,000万米ドルと評価され、2023年の73億9,000万米ドルから上昇し、予測期間(2024-2031年)のCAGRは11.2%で、2031年には155億5,000万米ドルに達すると予測されます。
市場成長の背景には、分析試験を必要とする臨床試験数の増加、バイオシミラーへの注目の高まり、製薬企業による分析試験サービスのアウトソーシングへの顕著なシフトなど、いくつかの重要な要因があります。COVID-19パンデミックは、この市場の拡大に重要な役割を果たしました。当初は、自宅待機命令とサプライチェーンの混乱による減速を引き起こしましたが、最終的にはワクチンと治療に対する緊急の必要性により成長に拍車をかけました。例えば、2020年7月のSGS SAとAstraZenecaの提携は、COVID-19ワクチンAZD1222に不可欠な分析試験サービスの需要を例示し、このようなサービスがいかにリスク低減を促進し、品質保証を加速し、規制コンプライアンスを確保できるかを実証しました。特にバイオシミラー、配合剤、その他の新規治療薬の出現により、技術革新と検査サービス需要の増加との相関関係は明らかです。さらに、競争の激化、迅速な市場参入への圧力、価格設定の課題により、製薬企業はこれらの試験サービスのアウトソーシングを進めています。新市場への進出には、現地の規制要件を満たす必要もあり、その結果、特定の種類の検査に対するニーズが高まっています。高度で信頼性の高い分析試験への需要が急増し続ける中、市場は成長軌道を維持すると予想されます。
Global Healthcare Analytical Testing Services Market size was valued at around USD 6.65 billion in 2022 and is expected to rise from USD 7.39 billion in 2023 to reach a value of USD 15.55 billion by 2031, at a CAGR of 11.2% over the forecast period (2024-2031).
Market growth is driven by several key factors, including a rising number of clinical trials necessitating analytical testing, an increasing focus on biosimilars, and a notable shift towards outsourcing analytical testing services by pharmaceutical companies. The COVID-19 pandemic has played a significant role in this market's expansion; initially causing a slowdown due to stay-at-home orders and disruptions in supply chains, it ultimately spurred growth due to the urgent need for vaccines and treatments. For instance, the collaboration between SGS SA and AstraZeneca in July 2020 exemplified the demand for analytical testing services crucial for the COVID-19 vaccine AZD1222, demonstrating how such services can facilitate risk reduction, accelerate quality assurance, and ensure regulatory compliance. The correlation between innovations and the increased demand for testing services is evident, especially with the advent of biosimilars, combination products, and other novel therapeutics. Furthermore, intensified competition, pressures for quicker market entry, and pricing challenges are driving pharmaceutical firms to outsource these testing services. Expansion into new markets also necessitates meeting local regulatory requirements, resulting in an increased need for specific testing types. As demand for advanced and reliable analytical testing continues to surge, the market is expected to maintain its growth trajectory.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Healthcare Analytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Healthcare Analytical Testing Services Market Segmental Analysis
Global Healthcare Analytical Testing Services Market is segmented by Type, End User, and Region. Based on Type, the market is segmented into Medical Device Analytical Testing Services (Extractable and Leachable, Material Characterization, Physical Testing, Bioburden Testing, Sterility Testing, Others), Pharmaceutical Analytical Testing Services (Bioanalytical Testing, Method Development & Validation, Stability Testing, Other Testing Services). Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Hospitals & Clinics, Forensic Labs, Cosmetic & Nutraceutical Companies. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Healthcare Analytical Testing Services Market
The Global Healthcare Analytical Testing Services market is significantly driven by the rising demand for medical testing services, fueled by the surging aging population and the escalating prevalence of chronic diseases. This demand is further amplified by the advent of personalized medicine, which relies on sophisticated diagnostic testing and analytical services for tailored treatment approaches. Additionally, substantial investments from healthcare professionals and the biopharmaceutical sector in enhancing analytical testing capabilities have provided robust momentum to the market. As the necessity for accurate and dependable diagnostic results intensifies, the ongoing expansion and adoption of healthcare testing services are expected to persist, bolstering market growth.
Restraints in the Global Healthcare Analytical Testing Services Market
The Global Healthcare Analytical Testing Services market faces significant restraints primarily due to high pricing and operational complexity. The cost associated with advanced analytical testing, which includes specialized software, sophisticated equipment, and the necessity for expert personnel, can deter small and medium-sized enterprises from investing in these essential services. Moreover, the intricate nature of testing processes compounds the risk of errors and inconsistencies, potentially undermining the integrity of results. This financial and operational burden makes it challenging for smaller firms to compete effectively, ultimately stunting market growth as stakeholders must carefully consider the balance between investment costs and anticipated benefits.
Market Trends of the Global Healthcare Analytical Testing Services Market
The Global Healthcare Analytical Testing Services market is witnessing a significant shift towards outsourcing, driven by cost reduction, technological advancements, and a focus on core competencies among biotechnology and pharmaceutical firms. As companies seek to enhance productivity and streamline operations, they increasingly turn to specialized service providers for analytical testing, allowing them to leverage external expertise and accelerate turnaround times. This trend is expected to grow, fueled by a rising demand for comprehensive analytical testing services that meet strict regulatory standards. Consequently, the outsourcing model is reshaping the market landscape, fostering innovation and efficiency in the healthcare sector.